| Nanomedicine-based immunotherapy for alzheimer's disease M Hoque, A Samanta, SSM Alam, TA Zughaibi, MA Kamal, S Tabrez Neuroscience & Biobehavioral Reviews 144, 104973, 2023 | 13 | 2023 |
| Tanshinone IIA targeting cell signaling pathways: A plausible paradigm for cancer therapy SSM Alam, A Samanta, F Uddin, S Ali, M Hoque Pharmacological Reports 75 (4), 907-922, 2023 | 5 | 2023 |
| Analysis of the compositional features and codon usage pattern of genes involved in human autophagy Z Jamil, A Uddin, SSM Alam, A Samanta, N Altwaijry, MA Rauf, S Ali, ... Cells 11 (20), 3203, 2022 | 5 | 2022 |
| Evaluating the transmission feasibility of SARS-CoV-2 Omicron (B. 1.1. 529) variant to 143 mammalian hosts: insights from S protein RBD and host ACE2 interaction studies A Samanta, SSM Alam, S Ali, M Hoque Functional & Integrative Genomics 23 (1), 36, 2023 | 4 | 2023 |
| Analyzing the interaction of human ACE2 and RBD of spike protein of SARS-CoV-2 in perspective of Omicron variant A Samanta, SSM Alam, S Ali, M Hoque EXCLI journal 21, 610, 2022 | 3 | 2022 |
| Nonsynonymous mutations in VEGF receptor binding domain alter the efficacy of bevacizumab treatment A Ahamed, A Samanta, SSM Alam, SA Mir, Z Jamil, S Ali, M Hoque Journal of Cellular Biochemistry 125 (2), e30515, 2024 | 2 | 2024 |
| Current status, challenges, and future perspective of nanomedicine-based cancer immunotherapy Z Sultana, Z Jamil, A Samanta, SSM Alam, S Ali, M Hoque Nanomedicine in Cancer Immunotherapy, 495-516, 2024 | 1 | 2024 |
| Codon usage patterns of the eleven SARS-CoV-2 variants with reference to the Wuhan sequence MS Hassan, SSM Alam, A Samanta, M Hoque, S Ali Gene Reports 34, 101861, 2024 | | 2024 |
| Lateral flow assay for SARS-CoV-2 infection: Uses and limitations M Islam, T Nasrin, A Samanta, S Ali, HS Buttar, M Hoque Linking Neuroscience and Behavior in COVID-19, 27-38, 2024 | | 2024 |
| The historical aspects of the SARS-CoV-2 virus and the ensuing pandemic T Nasrin, MS Hassan, A Samanta, M Hoque, S Ali Linking Neuroscience and Behavior in COVID-19, 3-11, 2024 | | 2024 |
| Different variants of SARS-CoV-2 A Samanta, MS Hassan, T Nasrin, SSM Alam, Z Jamil, HS Buttar, S Ali, ... Linking Neuroscience and Behavior in COVID-19, 13-25, 2024 | | 2024 |
| Liposome-based nanomedicines for cancer immunotherapy SSM Alam, A Samanta, Z Sultana, Z Jamil, S Ali, M Hoque Nanomedicine in Cancer Immunotherapy, 271-298, 2024 | | 2024 |
| Non-synonymous Single Nucleotide Polymorphisms in Human ACE2 Gene May Affect the Infectivity of SARS-CoV-2 Omicron Subvariants. A Samanta, A Ahamed, SSM Alam, S Ali, S Khan, AM Alamrid, S Tabrez, ... Current Pharmaceutical Design, 2023 | | 2023 |
| Prospective Pharmacological Potential of Cryptotanshinone in Cancer Therapy A Ahamed, M Hasan, A Samanta, SSM Alam, Z Jamil, S Ali, M Hoque Pharmacological Research-Modern Chinese Medicine, 100308, 2023 | | 2023 |
